cyclosporine has been researched along with Pancreatic Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bae, SK; Chung, BH; Doh, KC; Heo, SB; Jin, L; Lim, SW; Piao, SG; Yang, CW; Zheng, YF | 1 |
| Ahn, KO; Choi, YH; Chung, BH; Ito, S; Kim, J; Li, C; Lim, SW; Sugawara, A; Sun, BK; Yang, CW; Yang, JH; Yoon, KH | 1 |
| Horisawa, M; Ichihara, S; Ichihara, T; Kyokane, K; Morise, K; Nakao, A; Suga, S; Suzuki, N | 1 |
3 other study(ies) available for cyclosporine and Pancreatic Diseases
| Article | Year |
|---|---|
Oral administration of ginseng ameliorates cyclosporine-induced pancreatic injury in an experimental mouse model.
Topics: Administration, Oral; Animals; Apoptosis; Cyclosporine; Disease Models, Animal; Insulin-Secreting Cells; Islets of Langerhans; Kidney Function Tests; Macrophages; Mice; Nitrites; Oxidative Stress; Panax; Pancreas; Pancreatic Diseases; Plant Extracts | 2013 |
Rosiglitazone protects against cyclosporine-induced pancreatic and renal injury in rats.
Topics: Angiotensin II; Animals; Apoptosis; Cyclosporine; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hypoglycemic Agents; Immunosuppressive Agents; Insulin; Islets of Langerhans; Kidney; Osteopontin; Pancreatic Diseases; Rats; Rats, Sprague-Dawley; Rosiglitazone; Sialoglycoproteins; Thiazolidinediones; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Successful treatment of primary sclerosing cholangitis with cyclosporine and corticosteroid.
Topics: Aged; Cholangitis, Sclerosing; Cyclosporine; Drug Therapy, Combination; Humans; Male; Methylprednisolone; Pancreatic Diseases; Pancreatic Ducts; Remission Induction; Treatment Outcome | 1994 |